Heart Failure

heartwire News

  • Low Systolic BP Linked to Poor Outcomes in HFpEF The optimal systolic blood pressure target for heart failure with preserved ejection fraction is 'far from clear,' and aggressive SBP control in older patients with this condition may need to be avoided.
  • Fewer HF Readmissions After Cardiology vs Hospitalist Care Readmissions at 30 days were up for discharged patients with heart failure cared for on the general medicine service. A possible fix: more opportunities for hospitalists to learn strategies for optimal heart failure care.
  • Low-Dose Aspirin in Heart Failure Sans AF: Recommended or Not? It's an old question still, without much solid evidence either way. How much does a new cohort study from Denmark add to the debate? Views differ on whether aspirin should have a role in this population.
  • Alert FDA Expands Impella Pump Indications in High-Risk PCI, Shock The catheter-delivered temporary ventricular support pumps are now indicated for high-risk PCI regardless of LV function, and for shock secondary to cardiomyopathy, Abiomed announced.

Perspective

  • Patient Transition to Dialysis: Advice to Providers   Dr Szczech discusses the emotional challenges that patients with CKD face in their transition to dialysis, and offers suggestions to PCPs and pharmacists who see these patients.
  • Heart Defibrillators in CKD: More Harm Than Good? Dr Bansal comments on her study on heart defibrillators in patients with kidney disease and the greater risk for hospitalization for heart failure.
  • 7 Cardiology Trials to Look for in 2018   Trials on PCSK9 inhibitors, antiplatelets, anticoagulants, and even catheter ablation of atrial fibrillation are among Drs Harrington and Gibson's picks for what to look for in 2018.
  • Nine Things to Remember About CASTLE-AF Ablation of atrial fibrillation in patients with heart failure lowered all-cause mortality in this trial, but Dr Mandrola urges electrophysiologists not to overextrapolate these impressive results.